# TIcagrelor in Rotational Atherectomy to Reduce TROPonin Enhancement

> **NCT02505399** · PHASE4 · COMPLETED · sponsor: **University Hospital, Toulouse** · enrollment: 180 (actual)

## Conditions studied

- Atherosclerosis

## Interventions

- **DRUG:** ticagrelor
- **DRUG:** clopidogrel

## Key facts

- **NCT ID:** NCT02505399
- **Lead sponsor:** University Hospital, Toulouse
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11
- **Primary completion:** 2018-05-24
- **Final completion:** 2018-05-30
- **Target enrollment:** 180 (ACTUAL)
- **Last updated:** 2025-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02505399

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02505399, "TIcagrelor in Rotational Atherectomy to Reduce TROPonin Enhancement". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT02505399. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*